The largest database of trusted experimental protocols

Cyclo

Manufactured by Merck Group
Sourced in United States

The Cyclo is a piece of laboratory equipment designed for cell lysis and tissue homogenization. It utilizes a rotational mechanism to disrupt biological samples, allowing for the extraction and isolation of cellular components such as proteins, nucleic acids, and organelles. The Cyclo operates at consistent speeds and rotational forces to ensure efficient and reproducible sample preparation.

Automatically generated - may contain errors

5 protocols using cyclo

1

Apoptosis Induction by Apigenin, Etoposide, and Cyclophosphamide

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 1 × 106 per well in 12-well plates and treated with the lowest significant doses (LSDs) of apigenin (AP) (Sigma Aldrich, 10798) at 10 µM and 50 µM, etoposide (ETP) (Sigma Aldrich, E1383) at 0.01 µM and CYCLOphosphamide (CYCLO) (Sigma Aldrich, PHR1404) at 2 µM and 10 µM, alone or in combination; along with a vehicle control for 24 h. The therapeutic agents: AP, ETP, and CYCLO were prepared as described previously55 (link),63 (link),64 (link). LSDs capable of inducing apoptosis were selected based on our earlier published data55 (link),63 (link),64 (link) which caused a 10% to 20% increase in caspase-3 activity and induced apoptosis in THP-1 and Jurkat cells, when compared to the vehicle control.
+ Open protocol
+ Expand
2

Evaluating Cytotoxic Activity of TsV

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxic activity of TsV was evaluated using the MTT method described by Mosmann [18 (link)]. PBMC (5 × 105 cells/well) were cultured in 96-well plates in RPMI 1640 complete culture medium containing 10 % fetal calf serum (FCS) in the presence of TsV (12.5; 25.0; 50.0; 62.5; 100.0; 125.0; 250.0; 500.0; 1000.0; 2000.0 μg/mL) or Cyclophosphamide (Cyclo; 25 mg/mL; positive control; Sigma-Aldrich, USA) previously diluted in culture medium, for 24 h at 37 °C, and under 5 % CO2. Next, 20 μL of MTT (Sigma-Aldrich, USA) solution at 5 mg/mL was added to each well, and the plates were incubated for 4 h, at 37 °C, and under 5 % CO2. After incubation, the precipitated formazan crystals were dissolved with 200 μL of 20 % SDS (sodium dodecylsulfate), and absorbance was recorded at 570 nm. Absorbance values recorded for untreated cells (negative control) represent 100 % of PBMC viability, and were used as reference to calculate the percentage of cell viability in the presence of each sample concentration.
+ Open protocol
+ Expand
3

Pharmacological Modulation of Memory

Check if the same lab product or an alternative is used in the 5 most similar protocols
Midazolam (MDZ, 1.5, 3, or 5 mg/ml, Accord Healthcare Limited or Mylan), propranolol (PROP, 10 mg/ml, Sigma-Aldrich), CYCLOheximide (CYCLO, 1.5 mg/ml, Sigma-Aldrich) and D-CYCLOserine (DCS, 15 mg/ml, Sigma-Aldrich) were diluted/dissolved in sterile saline (SAL, 0.9%, w/v) (Espejo et al., 2017 (link)). Drugs (or equivalent amounts of SAL) were injected intraperitoneally (IP) at a volume of 1 ml/kg, except for CYCLO, which was administered subcutaneously. A volume of 2 ml/kg MDZ (5 mg/ml) was injected when a higher dose was used (experiment NS21, 10 mg/kg). Rats were semi-randomly assigned to treatment groups, with the restrictions that (1) each home cage contained at least one rat of each group, (2) rats from one group were not always tested in the same of four identical boxes during the behavioral sessions, (3) average post-shock freezing (%) during the conditioning session was comparable between groups.
+ Open protocol
+ Expand
4

LecB Regulation of Lung Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
H1299 and H1975 lung epithelial cells were grown at 37 °C and 5% CO2 in RPMI-1640 (Gibco) with 10% FCS and 2 mM l-glutamine (Gibco).
Lyophilized, recombinant LecB (Dr. Anne Imberty) was dissolved in PBS (with Ca/Mg) and used at concentrations of 0.09 μM, 0.9 μM and 4.3 μM for indicated time periods. Starvation in serum-free medium was performed, when indicated, for 2 h before treatment and maintained during stimulation. In order to block fucose-binding sites of LecB, l-fucose (Sigma-Aldrich) was directly dissolved in medium, sterile filtered and used at a final concentration of 43 mM for the same time periods as LecB. Other proteins for stimulation purposes were used at the following concentrations: Wnt3a (400 ng/ml, R&D Systems), TNF-α (10 ng/ml, Life Technologies) and staurosporine (Stauro, 1 μM, Sigma-Aldrich). The used inhibitors were pre-incubated for 30 min at 37 °C and maintained during stimulation at following concentrations: lactacystin (Lact, 10 μM, Biomol), bafilomycin (Baf, 0.2 μM, Invivogen), LY294002 (LY, 100 μM, Sigma-Aldrich), triciribine (TCN, 10 μM, Sigma-Aldrich), Akt1/2 inhibitor (Akti, 10 μM, Sigma-Aldrich), TWS119 (TWS, 20 μM, Selleckchem), lithium chloride (LiCl, 20 mM, Roth) and Cycloheximide (Cyclo, 100 μg/ml, Sigma-Aldrich).
+ Open protocol
+ Expand
5

Optimizing Cell Proliferation Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 2.5x103 cells/well and incubated overnight. Cycloheximide (Cyclo, protein translation/proliferation inhibitor, Sigma) and Latrunculin A (Lat A, actin stabilizer, Calbiochem) were added at 0, 50, 100, 200, and 500 nM concentrations for Cyclo and 0, 1, 5, 10, and 20 nm concentrations for Lat A for an additional 24 h incubation. Thiazolyl Blue Tetrazolium Bromide MTT solution was then added for 3 h followed by lysis of the cells. Absorbance was read at 570nm. For Cyclo, a value of 50% compared to control was considered satisfactory for blocking most of the proliferative capacity. For Lat A, a % viability greater than 80% was deemed necessary to avoid the impact of cell death on the measurements.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!